Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText.
Kick-your-searchterm to multiple Engines kick-your-query now !>
A dictionary by aggregated review articles of nephrology, medicine and the life sciences
Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

suck abstract from ncbi


10.1080/0886022X.2020.1798783

http://scihub22266oqcxt.onion/10.1080/0886022X.2020.1798783
suck pdf from google scholar
32718215!7472513!32718215
unlimited free pdf from europmc32718215    free
PDF from PMC    free
html from PMC    free

Warning: file_get_contents(https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&id=32718215&cmd=llinks): Failed to open stream: HTTP request failed! HTTP/1.1 429 Too Many Requests in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 215

suck abstract from ncbi

pmid32718215      Ren+Fail 2020 ; 42 (1): 733-739
Nephropedia Template TP

gab.com Text

Twit Text FOAVip

Twit Text #

English Wikipedia


  • When the COVID-19 pandemic changed the follow-up landscape of chronic kidney disease: a survey of real-world nephrology practice #MMPMID32718215
  • Chen G; Zhou Y; Xia J; Yao J; Zheng K; Qin Y; Li X
  • Ren Fail 2020[Nov]; 42 (1): 733-739 PMID32718215show ga
  • BACKGROUND: Patients with chronic kidney disease (CKD) require specialized management. However, the current situation of CKD management is unclear during the coronavirus disease 2019 (COVID-19) pandemic. We aimed to investigate the influence of the COVID-19 on kidney patients' follow-ups. METHODS: In April 2020, we included patients who underwent kidney biopsy from January 2017 to December 2019 in a referral center of China, and then initiated a survey via telephone on different aspects of follow-up during the COVID-19 pandemic. We collected and analyzed demographic data, diagnoses, follow-up conditions, and telemedicine experience. RESULTS: We reached 1190 CKD patients with confirmed kidney biopsies, and included 1164 patients for analysis after excluding those on dialysis. None of our patients have had COVID-19, although more than 50% of them were complicated with other comorbidities, and over 40% were currently using immunosuppressive treatments. Face-to-face clinic visits were interrupted in 836 (71.82%) participants. Medicine adjustments and routine laboratory examinations were delayed or made irregular in about 60% of patients. To continue their follow-ups, 255 (21.90%) patients utilized telemedicine, and about 80% of them were satisfied with the experience. The proportion of telemedicine users was significantly higher in patients with immunosuppressive treatments than those without (31.88% vs. 17.12%, p < 0.001). CONCLUSION: The risk of COVID-19 was mitigated in patients with CKD and other co-existing risk factors when proper protection was utilized. The routine medical care was disrupted during the pandemic, and telemedicine could be a reasonable alternative method.
  • |Adult[MESH]
  • |Biopsy, Needle[MESH]
  • |COVID-19[MESH]
  • |China/epidemiology[MESH]
  • |Communicable Diseases, Emerging/*epidemiology[MESH]
  • |Comorbidity[MESH]
  • |Coronavirus Infections/diagnosis/*epidemiology[MESH]
  • |Databases, Factual[MESH]
  • |Female[MESH]
  • |Follow-Up Studies[MESH]
  • |Humans[MESH]
  • |Immunohistochemistry[MESH]
  • |Incidence[MESH]
  • |Infection Control/*methods[MESH]
  • |Male[MESH]
  • |Middle Aged[MESH]
  • |Pandemics/*statistics & numerical data[MESH]
  • |Pneumonia, Viral/diagnosis/*epidemiology[MESH]
  • |Renal Insufficiency, Chronic/*epidemiology/*pathology/physiopathology[MESH]
  • |Retrospective Studies[MESH]
  • |Risk Assessment[MESH]


  • DeepDyve
  • Pubget Overpricing
  • suck abstract from ncbi

    Linkout box